RVMD - Balance Sheet - Revolution Medicines, Inc.

Current Liabilities	164 M
Accounts Payable	54.4 M
Short-Term Debt	0
Other Current Liabilities	109 M
Non-Current Liabilities	129 M
Long-Term Debt	0
Other Non-Current Liabilities	129 M

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018	Dec-2017
ASSETS
Cash & Cash Equivalents	543.1	696.1	161.4	108.5	104.3	16.7	69.6	9.1
Short Term Investments	1 746.2	1 156.8	483.5	468.6	336.5	106.1	0	0
Receivables	0	1.3	4.7	5.9	6.4	8.7	7.3	0
Inventory	0	0	1	(12.7)	0	1	6.6	0
Other Current Assets	38.3	25.1	10.6	6.8	7.0	2.5	8.5	0.4
Total Current Assets	2 327.6	1 879.3	660.2	577.1	454.1	134.0	85.4	9.4
PP&E	141.8	100.0	73.7	71.2	36.3	7.1	6.9	5.3
Intangible Assets	56.7	57.7	58.8	59.9	60.9	62.0	63.1	0
Goodwill	14.6	14.6	14.6	14.6	14.6	14.6	14.6	0
Long Term Investments	0	0	1.7	1.7	1.1	0.2	0.2	0
Other Long Term Assets	17.6	10.1	(23.4)	(14.5)	(19.1)	(8.3)	(2.5)	0.4
Other Assets	0	0	0	0	0	0	0	0
Total Assets	2 558.3	2 061.7	811.9	738.0	567.4	220.5	170.6	15.1
LIABILITIES
Accounts Payable	54.4	61.8	21.3	14.1	12.6	11.4	5.2	3.4
Short Term Debt	0	7.4	13.5	12.4	3.7	0.2	0.1	0
Other Current Liabilities	109.5	74.7	22.7	21.5	18.8	14.3	8.3	4.2
Total Current Liabilities	163.9	143.9	62.0	18.9	47.2	43.1	30.6	7.6
Long Term Debt	0	80.6	57.4	60.4	29.0	0	0	0
Deferred Tax Income	2.4	3.1	7.0	7.4	7.4	7.8	12.2	0
Other Liabilities	126.8	8.0	0.3	0.6	0.6	2.4	2.8	2.9
Total Liabilities	293.1	235.5	126.7	135.4	92.7	68.0	73.9	10.5
EQUITY
Common Stock	18 K	16 K	9 K	8 K	7 K	0	3 K	1 K
Retained Earnings	(1 737.8)	(1 137.7)	(701.3)	(452.6)	(265.5)	(157.4)	(109.7)	(67.9)
Other Accumulative Comprehensive Income/Loss	1.3	0.5	(1.8)	(0.4)	0.1	74 K	(3.6)	(2.2)
Total Equity	2 265.2	1 826.2	685.2	602.6	474.7	152.5	96.7	4.5
Total Liabilities and Equity	2 558.3	2 061.7	811.9	738.0	567.4	220.5	170.6	15.1
SHARES OUTSTANDING
Common Shares Outstanding	167.7	113.1	80.6	72.8	66.6	59.0	36.5	36.5

Free